Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Sleep Disorders Clinical Presentation

  • Author: Roy H Lubit, MD, PhD; Chief Editor: Iqbal Ahmed, MBBS, FRCPsych(UK)  more...
 
Updated: Jan 28, 2015
 

History

Insomnia may present as decreased sleep efficiency or decreased total hours of sleep, with some associated decrease in productivity or well-being. Because sleep requirements vary from person to person, the quality of sleep is more important than the total number of hours slept. The total number of hours slept should be compared with each individual’s lifelong normal night sleep time.

Initial insomnia (also referred to as early insomnia or sleep-onset insomnia) is characterized by difficulty in falling asleep, with an increase in sleep latency (ie, the time between going to bed and falling asleep). Initial insomnia is frequently related to anxiety disorders.

Middle insomnia (also referred to as sleep-maintenance insomnia) refers to difficulty in maintaining sleep. Decreased sleep efficiency is present, with fragmented unrestful sleep and frequent waking during the night. Middle insomnia may be associated with medical illness, pain syndromes, or depression.

In terminal insomnia (also referred to as late insomnia or early morning wakening insomnia), patients consistently wake up earlier than needed. This symptom is frequently associated with major depression.

Alterations of the sleep-wake cycle may be a sign of circadian rhythm disturbances, such as those caused by jet lag and shift work.

Hypersomnia, or excessive daytime sleepiness, is often attributable to ongoing sleep deprivation or poor-quality sleep arising from causes ranging from sleep apnea to substance abuse or medical problems.

In delayed sleep phase syndrome, the patient is unable to fall asleep until very early morning. As time progresses, the onset of sleep becomes progressively delayed.

Sleepwalking, also called somnambulism, refers to episodes of complex behaviors occurring during non–rapid eye movement (NREM) sleep (stages 3 and 4), of which the patient is amnestic afterward.

Nightmares are repeated awakenings from sleep caused by vivid and distressing recall of dreams. Nightmares usually occur during the second half of the sleep period. Upon wakening from the dream, the person rapidly reorients to time and place.

Night terrors are recurrent episodes of abrupt awakening from sleep characterized by a panicky scream, with intense fear and autonomic arousal. The individual usually has no recall of the details of the event and is unresponsive during the episode. Night terrors occur during the first third of the night, during stages 3 and 4 of NREM sleep.

Bed partners of patients who snore may provide a history of snoring. Such a history may help determine whether a patient experiences obstructive sleep apnea (OSA).

Next

Physical Examination

Signs of sleep disorders include the following:

  • Hypertension (which can be caused by sleep apnea)
  • Disturbed coordination (which can be caused by sleep deprivation)
  • Drowsiness
  • Poor concentration
  • Slowed reaction time
  • Weight gain
Previous
Next

Complications

Mood and anxiety disorders may develop from untreated sleep disturbances, and current medical literature supports the theory that these brain-based mental status changes are risk factors for morbidity and mortality from a host of medical conditions (eg, cardiovascular disease).

Caution is advised in the treatment of patients who are elderly and others who may be at increased risk for falls.

Previous
 
 
Contributor Information and Disclosures
Author

Roy H Lubit, MD, PhD Private Practice

Roy H Lubit, MD, PhD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry

Disclosure: Nothing to disclose.

Coauthor(s)

Curley L Bonds, II, MD Professor and Chair, Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science; Health Sciences Clinical Professor, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine

Curley L Bonds, II, MD is a member of the following medical societies: Academy of Psychosomatic Medicine, American Medical Association, National Medical Association, American Psychiatric Association

Disclosure: Nothing to disclose.

Michael A Lucia, MD, FAASM Owner/CEO, Pulmonary, Allergy and Sleep Medicine, Sierra Pulmonary and Sleep Consultants, LLC

Michael A Lucia, MD, FAASM is a member of the following medical societies: Nevada State Medical Association, American Academy of Sleep Medicine, American Association of Cardiovascular and Pulmonary Rehabilitation

Disclosure: Nothing to disclose.

Chief Editor

Iqbal Ahmed, MBBS, FRCPsych(UK) Faculty, Department of Psychiatry, Tripler Army Medical Center; Clinical Professor of Psychiatry, Uniformed Services University of the Health Sciences; Clinical Professor of Psychiatry, Clinical Professor of Geriatric Medicine, University of Hawaii, John A Burns School of Medicine

Iqbal Ahmed, MBBS, FRCPsych(UK) is a member of the following medical societies: Academy of Psychosomatic Medicine, American Neuropsychiatric Association, American Society of Clinical Psychopharmacology, Royal College of Psychiatrists, American Association for Geriatric Psychiatry, American Psychiatric Association

Disclosure: Nothing to disclose.

Acknowledgements

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

References
  1. Zammit GK, Weiner J, Damato N, et al. Quality of life in people with insomnia. Sleep. 1999 May 1. 22 Suppl 2:S379-85. [Medline].

  2. Chen Q, Hayman LL, Shmerling RH, Bean JF, Leveille SG. Characteristics of Chronic Pain Associated with Sleep Difficulty in Older Adults: The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly (MOBILIZE) Boston Study. J Am Geriatr Soc. 2011 Aug. 59(8):1385-92. [Medline].

  3. Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 2011 Aug 10. 306(6):613-9. [Medline].

  4. Rajaratnam SM, Barger LK, Lockley SW, et al. Sleep disorders, health, and safety in police officers. JAMA. 2011 Dec 21. 306(23):2567-78. [Medline].

  5. Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009 May 20. 301(19):2005-15. [Medline].

  6. Elie R, Ruther E, Farr I, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. J Clin Psychiatry. 1999 Aug. 60(8):536-44. [Medline].

  7. Lockley S, Dressman M, Xiao C, Fisher D, Torres R, Lavedan C, et al. Tasimelteon treatment entrains the circadian clock and demonstrates a clinically meaningful benefit blind individuals with non-24-hour circadian rhythms. Presented at ENDO 2013: the Endocrinology Society 95th Annual Meeting. San Francisco. (SUN-134).

  8. Lockley S, Dressman M, Xiao C, Licamele L, Polymeropoulos M. RESET study demonstrates that tasimelteon maintains entrainment of melatonin and cortisol in totally blind individuals with non-24-hour circadian rhythms. Presented at ENDO 2013: the Endocrinology Society 95th Annual Meeting. San Francisco. (SUN-137).

  9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.

  10. Anders TF, Eiben LA. Pediatric sleep disorders: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997 Jan. 36(1):9-20. [Medline].

  11. Benca RM, Ancoli-Israel S, Moldofsky H. Special considerations in insomnia diagnosis and management: depressed, elderly, and chronic pain populations. J Clin Psychiatry. 2004. 65 Suppl 8:26-35. [Medline].

  12. Bryant PA, Trinder J, Curtis N. Sick and tired: Does sleep have a vital role in the immune system?. Nat Rev Immunol. 2004 Jun. 4(6):457-67. [Medline].

  13. Chen W, Kushida CA. Nasal obstruction in sleep-disordered breathing. Otolaryngol Clin North Am. 2003 Jun. 36(3):437-60. [Medline].

  14. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA. 1989 Sep 15. 262(11):1479-84. [Medline].

  15. Gillin JC, Byerley WF. Drug therapy: The diagnosis and management of insomnia. N Engl J Med. 1990 Jan 25. 322(4):239-48. [Medline].

  16. Hauri PJ, Hayes B, Sateia M, et al. Effectiveness of a sleep disorders center: a 9-month follow-up. Am J Psychiatry. 1982 May. 139(5):663-6. [Medline].

  17. Kaplan HI, Sadock BJ, Grebb JA. Normal sleep and sleep disorders. Kaplan and Sadock's Synopsis of Psychiatry. 7th ed. Baltimore, Md: Williams & Wilkins; 1994. 699-716.

  18. Lamberg L. Promoting adequate sleep finds a place on the public health agenda. JAMA. 2004 May 26. 291(20):2415-7. [Medline].

  19. Lamberg L. Sleep-disordered breathing may spur behavioral, learning problems in children. JAMA. 2007 June. 27;297(24):2681-3. [Medline].

  20. Loewy DH, Black JE. Effective management of transient and chronic insomnia. CNS News. McMahon Publishing Group: New York, NY; 2000. 19-22. [Full Text].

  21. No authors listed. Beauty sleep for the heart. Harv Heart Lett. 2004 May. 14(9):7. [Medline].

  22. Richert AC, Baran AS. A review of common sleep disorders. CNS Spectr. 2003 Feb. 8(2):102-9. [Medline].

  23. Schuen JN, Millard SL. Evaluation and treatment of sleep disorders in adolescents. Adolesc Med. 2000 Oct. 11(3):605-16. [Medline].

  24. Schwab RJ. Disturbances of sleep in the intensive care unit. Crit Care Clin. 1994 Oct. 10(4):681-94. [Medline].

  25. Veasey SC. Sedating, not treating sleep apnea: hit & run in primary care. J Clin Sleep Med. 2005 Oct 15. 1(4):372-3. [Medline].

  26. Zorner D, Geisler P. [Diagnostic Spectrum and Filtration Function of Outpatient Sleep Clinics]. Psychiatr Prax. 2003 May. 30(Suppl 2):173-175. [Medline].

  27. Belsomra (survorexant) prescribing information. [package insert]. Whitehouse Station, NJ 08889: August, 2014. Available at [Full Text].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.